So far, plasma methylation of SEPT9 seems to have the highest sensitivity and specificity (reaching 95.6% and 84.8% respectively) for CRC, although these values drop to 9.6% for adenomas [46, 47]. Here, SEPTIN9 is linked to colorectal carcinoma.